Qualigen Therapeutics Inc
NASDAQ:QLGN
Qualigen Therapeutics Inc
Other Assets
Qualigen Therapeutics Inc
Other Assets Peer Comparison
Competitive Other Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Assets
$33.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Assets
$8.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Assets
$18.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Assets
$1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
85%
|
CAGR 10-Years
43%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|